SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001437749-18-017205
Filing Date
2018-09-19
Accepted
2018-09-19 16:27:37
Documents
3
Group Members
BRADLEY J. HAYOSHJEFFREY S. STARMAN

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G equidebt20180919_sc13g.htm SC 13G 125911
2 EXHIBIT 99.A ex_124237.htm EX-99.A 13308
3 EXHIBIT 99.B ex_124238.htm EX-99.B 10142
  Complete submission text file 0001437749-18-017205.txt   150893
Mailing Address 100 PHOENIX DRIVE SUITE 190 ANN ARBOR MI 48108
Business Address 100 PHOENIX DRIVE SUITE 190 ANN ARBOR MI 48108 (734) 369-2555
Zomedica Pharmaceuticals Corp. (Subject) CIK: 0001684144 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90186 | Film No.: 181077964
SIC: 2834 Pharmaceutical Preparations

Mailing Address 230 HURONVIEW BLVD. ANN ARBOR MI 48103
Business Address 230 HURONVIEW BLVD. ANN ARBOR MI 48103 7343692100
EQUIDEBT LLC (Filed by) CIK: 0001753306 (see all company filings)

IRS No.: 455450489 | State of Incorp.: MI | Fiscal Year End: 1231
Type: SC 13G